Clinical Trial Update: Intranasal Ketamine as a Sedative for Venipuncture [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating intranasal ketamine as a sedative for venipuncture has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diseases of the Digestive System
• Diseases of the Respiratory System
• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Respiratory Tract Disease, Acute Pain | Phase 2, Phase 3 | Status: COMPLETED